SavedAdd your journal

Journals / Türk Radyoloji Seminerleri / 2016 / Cilt: 4 - Sayı: 1

Beyin Gliomlarında Manyetik Rezonans Görüntüleme

Merve YAZOL
ALİ YUSUF ÖNER
Pages
20–36
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

YAZOL, M., ÖNER, A. Y. (2016). Beyin Gliomlarında Manyetik Rezonans Görüntüleme. Türk Radyoloji Seminerleri, Cilt: 4 - Sayı: 1, 20–36. https://ajindex.com/articles/357799

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. . Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007
  2. [CrossRef] [2]. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007
  3. [CrossRef] [3]. Bangiyev L, Rossi Espagnet MC, Young R, Shepherd T, Knopp E, Friedman K, et al. Adult brain tumor imaging: state of the art. Semin Roentgenol 2014
  4. [CrossRef] [4]. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008
  5. [CrossRef] [5]. Lee YY, Van Tassel P. Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. AJR Am J Roentgenol 1989
  6. [CrossRef] [6]. Rees JH, Smirniotopoulos JG, Jones RV, Wong K. Glioblastoma multiforme: radiologic-pathologic correlation. Radiographics 1996
  7. [CrossRef] [7]. Barajas RF Jr, Hess CP, Phillips JJ, Von Morze CJ, Yu JP, Chang SM, et al. Super-resolution track density imaging of glioblastoma: histopathologic correlation. AJNR Am J Neuroradiol 2013
  8. [CrossRef] [8]. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006
  9. . Upadhyay N, Waldman AD. Conventional MRI evaluation of gliomas. Br J Radiol 2011
  10. S107- 11. [CrossRef] [10]. Sorensen AG, Batchelor TT, Wen PY, Zhang WT, Jain RK. Response criteria for glioma. Nat Clin Pract Oncol 2008
  11. [CrossRef] [11]. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010
  12. [CrossRef] [12]. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008
  13. [CrossRef] [13]. Taal W, Brandsma D, de Bruin HG, Bromberg JE, Swaak-Kragten AT, Smitt PA, et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer 2008
  14. [CrossRef] [14]. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007
  15. [CrossRef] [15]. Haacke EM, X